BioCentury
ARTICLE | Company News

Ixchelsis, Eli Lilly, Pfizer deal

August 12, 2013 7:00 AM UTC

Ixchelsis said in July it acquired rights to IX-01 from Pfizer in exchange for an undisclosed equity stake. The pharma also is eligible for undisclosed milestones and royalties. The oxytocin recepto...